Association of mitochondrial displacement loop polymorphisms with diarrhea-predominant irritable bowel syndrome: A preliminary study

被引:4
|
作者
Liu, Zi Yu [1 ]
Gua, Xia Xu [1 ]
Zhang, Rong Gui [1 ]
Wang, Xiao Xiao [1 ]
Ai, Jie [1 ]
Wang, Wei Feng [1 ,2 ]
Yang, Yun Sheng [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol & Hepatol, 28 Fuxing Rd, Beijing 100853, Peoples R China
[2] Shenzhen Univ, Div Gastroenterol & Hepatol, Hlth Sci Ctr, Shenzhen, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
diarrhea; DNA; irritable bowel syndrome; mitochondria; single nucleotide polymorphism; DNA POLYMORPHISMS; LEIGH-SYNDROME; CONTROL REGION; DISEASE; MTDNA; DISORDERS; MUTATION; ANTIDEPRESSANTS; POPULATION; LONGEVITY;
D O I
10.1111/1751-2980.12597
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVESTo investigate whether single nucleotide polymorphisms (SNPs) in the mitochondrial displacement loop (D-loop) were associated with irritable bowel syndrome (IBS). METHODSAltogether 40 participants were recruited and classified into three groups, including 20 that fulfilled the Rome III criteria for diarrhea-predominant IBS (IBS-D), 10 with constipation-predominant IBS (IBS-C), and 10 healthy volunteers (controls). DNA was extracted from biopsy specimens of the colon obtained during routine colonoscopies. The mitochondrial D-loop was sequenced and variants were identified in comparison with the reference sequence from GenBank. We searched GenBank and MITOMAP to determine whether a variant could be considered an SNP. RESULTSNo significant differences in sex, age and body mass index were found among the three groups. The average numbers of SNPs in the IBS-D, IBS-C and control groups were 12.22.7, 9.8 +/- 1.8 and 9.9 +/- 2.1, respectively. The frequency of SNPs was significantly higher in the IBS-D group than in the IBS-C group and controls (P < 0.05). No significant difference was found between the latter two groups. Each SNP was compared among the three groups and the frequency of 199C was found to be significantly higher in the control group than in the IBS-D group (P =0.03), but no significant difference in its frequency was found between the IBS-C group and controls. CONCLUSIONSPatients with IBS-D have a higher incidence of SNPs in the mitochondrial D-loop than controls. The genotype 199C may be associated with a lower risk of IBS-D.
引用
收藏
页码:295 / 300
页数:6
相关论文
共 50 条
  • [11] Clinical Study on Acupuncture in Treating Diarrhea-predominant Irritable Bowel Syndrome
    刘慧荣
    杨允
    吴焕淦
    肖元春
    Journal of Acupuncture and Tuina Science, 2008, 6 (06) : 360 - 362
  • [12] Factorial study of moxibustion in treatment of diarrhea-predominant irritable bowel syndrome
    Zhao, Ji-Meng
    Wu, Lu-Yi
    Liu, Hui-Rong
    Hu, Hong-Yi
    Wang, Jia-Ying
    Huang, Ren-Jia
    Shi, Yin
    Tao, Shan-Ping
    Gao, Qiang
    Zhou, Ci-Li
    Qi, Li
    Ma, Xiao-Peng
    Wu, Huan-Gan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (37) : 13563 - 13572
  • [13] ChREBP deficiency leads to diarrhea-predominant irritable bowel syndrome
    Oh, Ah-Reum
    Sohn, Seonyong
    Lee, Junghoon
    Park, Jong-Min
    Nam, Ki Taek
    Hahm, Ki-Baik
    Kim, Young-Bum
    Lee, Ho-Jae
    Cha, Ji-Young
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2018, 85 : 286 - 297
  • [14] Alosetron: an effective treatment for diarrhea-predominant irritable bowel syndrome
    Harris, Lucinda A.
    Chang, Lin
    WOMENS HEALTH, 2007, 3 (01) : 15 - 27
  • [15] Mesalamine Improve Symptoms of Diarrhea-Predominant Irritable Bowel Syndrome
    Bafutto, Mauro
    Bafutto, Alexandre A.
    Oliveira, Enio C.
    Rezende Filho, Joffre
    GASTROENTEROLOGY, 2013, 144 (05) : S540 - S540
  • [16] Ultrastructure of intestinal mucosa in diarrhea-predominant irritable bowel syndrome
    Zhao, D-Y
    Qi, Q-Q
    Long, X.
    Li, X.
    Chen, F-X
    Yu, Y-B
    Zuo, X-L
    PHYSIOLOGY INTERNATIONAL, 2019, 106 (03) : 225 - 235
  • [17] The Fecal Microbiome in Children With Diarrhea-Predominant Irritable Bowel Syndrome
    Michail, Sonia
    Kenche, Harshavadran
    GASTROENTEROLOGY, 2010, 138 (05) : S14 - S14
  • [18] Advancements in drug development for diarrhea-predominant irritable bowel syndrome
    Dothel, Giovanni
    Barbaro, Maria Raffaella
    Raschi, Emanuel
    Barbara, Giovanni
    De Ponti, Fabrizio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (03) : 251 - 263
  • [19] Diagnostic Yield of Testing in Diarrhea-predominant Irritable Bowel Syndrome
    Manolakis, Catherine
    Di Palma, Jack
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S490 - S490
  • [20] Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome
    Dai, Cong
    Jiang, Min
    Sun, Ming-Jun
    GASTROENTEROLOGY, 2017, 152 (06) : 1629 - +